42 results about "Erythroplakia" patented technology

The invention relates to a medicament for treating cheek erythema and a preparation method thereof. The medicament which can be absorbed well and stored for a long term, has stable curative effect and can directly act on the skin and mucosa is prepared by purifying various active ingredients of different medicaments and mixing the active ingredients further by reasonable preparation technology. The medicament is used for treating the cheek erythema in lupus erythematosus. A large number of animal experiments prove that the medicament has the advantages of no toxic or side effect and reliable curative effect.

The invention discloses a traditional Chinese medicine composition for treating systemic lupus erythematosus. The traditional Chinese medicine composition is prepared from the following components in parts by weight: 15-30 parts of buffalo horn sheets, 20-30 parts of oldenlandia diffusa, 10-20 parts of radix rehmanniae, 10-15 parts of fructus forsythiae, 10-20 parts of radix paeoniae alba, 10-20 parts of cortex moutan, 10-15 parts of gentiana macrophylla, 15-20 parts of lalang grass rhizome and 10-15 parts of fried atractylodes macrocephala. The invention also discloses a preparation method and application of the traditional Chinese medicine composition for treating systemic lupus erythematosus. According to the formula, the traditional Chinese medicine composition has the favorable effects of inhibiting the generation of an autoantibody, forming an immune complex and inhibiting type-III allergic reaction, has favorable analgesic and anti-inflammatory effects, has a remarkable effect in clinical treatment and has a better effect as comparison with preliminarily-researched Langchuangqing granules, in addition, the formula is simple, the dosage is reduced, and caulis sinomenii serving as a poisonous traditional Chinese medicine in the formula is removed, so that the traditional Chinese medicine composition prepared according to the formula has more advantages from the views of safety and effectiveness as comparison with the Langchuangqing granules.

The invention belongs to the field of traditional Chinese medical care, and particularly relates to hydrogel for slow release of tripterygium hypoglaucum hutch extract and a paper diaper for the aged made of the same.Esterified chitosan serves as the water-soluble nano-porous frame carrier of the hydrogel, and the tripterygium hypoglaucum hutch extract serves as the solubilization slow release object.The paper diaper for the aged comprises a healthcare protection layer, an adsorption core coating layer, an adsorption core layer and a nano-hydrogel layer from outside to inside in sequence, wherein the nano-hydrogel layer is mainly formed by the hydrogel for slow release of the tripterygium hypoglaucum hutch extract.The hydrogel for slow release of the tripterygium hypoglaucum hutch extract can effectively reduce the peak plasma concentration of drugs and is a slow release preparation with a remarkable treatment effect.By the adoption of the paper diaper for the aged, the trouble of frequent clinical medication everyday and problems caused thereby are avoided, and medication efficiency and safety and patient compliance are improved.The paper diaper for the aged is mainly used for adjuvant treatment of rheumatoid arthritis, lupus erythematosus, chronic nephritis and autoimmune hemolytic anemia.

The invention provides a Chinese traditional medicine for treating pruritus, which comprises the following traditional Chinese medicinal herbs (by weight portion), Sichuan coptis 4-20 parts, buthus martensi kirsch 3-18 parts, joss robe 5-18 parts, white atractylodes rhizome 8-25 parts, and is prepared into oral preparation and external soup by means of conventional methods.

The invention discloses a medicinal composition for treating dermatomyositis. The medicinal composition is prepared from the following main raw materials in part by weight: 100 to 200 parts of buffalo horn, 10 to 100 parts of tripterygium wilfordii, 100 to 200 parts of rehmannia root, 10 to 100 parts of rhubarb, 100 to 200 parts of sweet wormwood herb, 100 to 200 parts of red-rooted salvia root, 100 to 200 parts of suberect spatholobus stem, 100 to 200 parts of astragalus, 10 to 100 parts of epimedium herb and 10 to 100 parts of liquoric root. A preparation method for the medicinal composition comprises the following steps of: weighing the raw materials according to a formula, and uniformly mixing the raw materials by crush and water extraction and concentration or in a mode of combining the crush and the water extraction and concentration to obtain the medicinal composition. The medicinal composition can clear heat and cool blood, remove toxicity and dredge collaterals, tonify qi, strengthen the body resistance and nourish blood, and is used for fever, erythema, pain of joints and muscle, swell, laborious activity and the like caused by systemic lupus erythematosus, dermatomyositis and other rheumatism immunological diseases.

A Chinese medicine including interior-applied and exterior-applied medicines for whitening skin and treating pigmented spots, pigmentation, itching, skin rash, photosensitive dermatitis, etc is prepared from 4-5 Chinese-medicinal materials including ash bark, mulberry leaf, buffalo horn, etc.

The invention provides a Chinese herbal preparation for treating posirasis, which adopts 58 raw medicinal materials such as astragalus root, suberect spatholobus stem, Job stears, glabrous greenbrier rhizome, spreading hedyotis herb, barbed skullcap herb, motherwort herb and the like to manufacture oral agent and abrasive cleaner. The manufacturing method of the invention is as follows: 1. manufacturing by using the above raw material medicines into water-decocted liquid according to the conventional method; 2. manufacturing by using the water-decocted liquid which is manufactured in step 1 into oral liquid according to the conventional method; 3. drying, grinding and sieving the water-decocted liquid which is manufactured in step 1, and taking the throughs as powder; and 4. manufacturing into powder tablets, granular formulation, medicinal granules or capsules by utilizing step 3 according to the conventional method. The powder and the abrasive cleaner can be manufactured by the following steps: 1. grinding the above raw material medicines; 2. sieving; and 3. taking the throughs, disinfecting and sterilizing to obtain the powder. The invention has high cure rate, low recurrence rate, can treat the primary and the secondary aspects at the same time, is safe and reliable, and can strengthen the autoimmunity. The invention mainly treats various types of posirasis, can treat neurodermatitis, comedo, acne and eczema concurrently, and has effects on lupus erythematosus, syphilis, lepra and skin cancer.

The invention belongs to the field of pharmacy, and specifically relates to an immunosuppressive drug and a preparation method thereof, which extracts a monomer compound norzeramydal from Tripterygium wilfordii as an active ingredient. The monomer compound norzeramydal of the present invention can be used as a drug raw material to make oral sustained-release preparations, soft capsules, injections, ointments and the like. The immunosuppressive drug of the present invention has few toxic side effects, wide sources, low production cost, cheap price, and convenient application. The drug of the present invention has obvious anti-rejection effect after organ transplantation, and can also be used to treat other clinical autoimmune diseases such as lupus erythematosus Wait.

The invention discloses a medicament for treating burn, scald, frostbite, wound and symptoms of red, swell, pain, itch, pus and ulcer on various parts of the body surface. The medicament is mainly prepared from scorpio, scorpion, periostracum serpentis, eupolyphaga, rabiagar, saffron and hydrargyri oxydum rubrum according to a certain weight ratio. The medicament disclosed by the invention has the efficacies of relieving pain and itching (5-10 seconds), diminishing inflammation, sterilizing, healing wound and sore, removing the swelling and stasis (3-40 minutes) and resisting infection and tetanus, can be used for treating trauma and foreign invasion with symptom wound surfaces and has quick response and treatment rate and no scar left after the wound is cured. The medicament has the functions of inhibiting and killing staphylococcus aureus, streptococcus, anaerobic bacteria, fugus and gram-negative bacilli as well as eczema, urticaria, impetigo, decubitus, herpes zoster, lupus erythematosus, acne and pimple, various bite wound and stings by varipus animals and plants, and the like. The invention emphasizes on making up the defects of singleness, low effect, long period, and the like of the present relative medicaments and solves the problems of inadequate and unaffordable medical services for a part of patients in true sense.